Subsidiary of ApicHope Pharmaceutical Group (300723.SZ) obtains registration certificate for Injection of New Simec Met.

ApicHope Pharmaceutical Group (300723.SZ) announced that its wholly-owned subsidiary, Guangzhou Lianrui Pharmaceuticals Co., Ltd. recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for the Thiocholine Sulfate Injection. The Thiocholine Sulfate Injection is indicated for: anticholinesterase drugs. It is used to antagonize the residual muscle relaxation effects of non-depolarizing neuromuscular blocking agents at the end of surgery, as well as for myasthenia gravis, postoperative functional intestinal gas retention, and urinary retention.